Skip to main content
. 2021 Nov 17;10(11):1406. doi: 10.3390/antibiotics10111406
A a-site tRNA
ABC ATP-binding-cassette
ABC-f ATP-binding-cassette family
CA-MRSA community-associated methicillin resistance Staphylococcus aureus
CLSI Clinical and Laboratory Standards Institute
cMLSB constitutive macrolides, lincosamides and streptogramin B phenotype
E e-site tRNA
Erm erythromycin resistance methylase
EUCAST European Committee on Antimicrobial Susceptibility Testing
FDA Food and Drug Administration
HA-MRSA hospital-acquired methicillin resistance Staphylococcus aureus
hVISA heterogeneous vancomycin intermediate-resistance Staphylococcus aureus
iMLSB inductive macrolides, lincosamides, and streptogramin B phenotype
LA-MRSA livestock-associated methicillin resistance Staphylococcus aureus
MAC-MRSA Macrolide-resistant methicillin-resistant Staphylococcus aureus
MIC minimal inhibitory concentration
MDR multi-drug resistance
MLSB macrolides, lincosamides and streptogramin B
MSB phenotype of resistance to macrolides and streptogramin B
MRSA methicillin resistance Staphylococcus aureus
MSD membrane spanning domains
MSSA methicillin sensitive Staphylococcus aureus
NBD nucleotide binding domains
NPET nascent peptide exit tunnel
ORF open reading frame
P p-site tRNA
PCT phenyl transferase center
PRSA penicillin resistance Staphylococcus aureus
RBS ribosome binding site
TMD transmembrane domains
WHO World Health Organization
VISA vancomycin intermediate-resistance Staphylococcus aureus
VRSA vancomycin resistance Staphylococcus aureus